Heather Landau, MD Memorial Sloan Kettering Cancer Center Interview Date: February 28, 2017
Many multiple myeloma patients can also have amyloidosis - or protein buildup in specific organs. Dr. Heather Landau of the Memorial Sloan Kettering cancer center explains the different kinds of amyloidosis, current treatments and exciting clinical trials for these patients. These trials include myeloma drugs such as Ninlaro, carfilzomib, daratumumab and other standard treatments, but also a new drug called NEOD001 that can reverse amyloidosis in certain organs. This is a very informative show for amyloidosis patients with or without multiple myeloma.
Thanks to our episode sponsor
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113